{"url_path":"/sec/clpt/8-k/2026-05-21/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-21","source_url":"https://www.sec.gov/Archives/edgar/data/1285550/0001193125-26-234571-index.html","accession_number":"0001193125-26-234571","cik":"0001285550","ticker":"CLPT","issuer_name":"ClearPoint Neuro, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1285550/0001193125-26-234571-index.html","primary_entity_key":"0001285550","primary_entity_name":"ClearPoint Neuro, Inc."},"word_count":86,"has_tables":true,"body_markdown":"Item 9.01. Financial Statements and Exhibits.\n\n(d) Exhibits.\n\n \n\nExhibit No.\n\nDescription of Exhibit\n\n \n\n10.1\n\n \n\n \n\n[ClearPoint Neuro, Inc. Seventh Amended and Restated 2013 Incentive Compensation Plan.](clpt-ex10_1.htm)\n\n104\n\n \n\nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n \n\n-3-\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \n\nDate: May 21, 2026\n\nCLEARPOINT NEURO, INC.\n\n \n\n \n\n \n\nBy:\n\n/s/ Danilo D’Alessandro\n\nDanilo D’Alessandro\n\nChief Financial Officer\n\n \n\n \n\n-4-"}